Furthermore, previous research has highlighted the clinical significance of CD32b in promoting M2 activation, with M2-mediated TAM activation implicated in tumor growth promotion through various mechanisms, such as angiogenic regulation, immune suppression, and metastasis facilitation [3,5]. The gene discussed is FCGR2B; the disease is neoplasm.